Alnylam Pharmaceuticals saw the highest growth of 120% in patent filings in February and 110% in grants in January in Q1 2024. Compared to Q4 2023, Q1 2024 saw an increase in patent filings by 106% and grants by 110%. GlobalData’s DataBook provides a comprehensive analysis of Alnylam Pharmaceuticals‘s patent filings and grants. Buy the databook here.

Smarter leaders trust GlobalData

Alnylam Pharmaceuticals has been focused on protecting inventions in United States(US) with 20 publications in Q1 2024

The United States(US) Patent Office dominates the patent filings and grants with nearly 11% filings and 35% grants. The European Patent Office(EPO), Australia(AU), Israel(IL), and United States(US) patent Office are among the top ten patent offices where Alnylam Pharmaceuticals is filings its patents. Among the top granted patent authorities, Alnylam Pharmaceuticals has 35% of its grants in United States(US), 15% in Israel(IL) and 8% in Australia(AU).

Arrowhead Pharmaceuticals and Novo Nordisk Foundation could be the strongest competitors for Alnylam Pharmaceuticals

Patents related to rare diseases and climate change lead Alnylam Pharmaceuticals's portfolio

Alnylam Pharmaceuticals has the highest number of patents in rare diseases followed by, climate change and nanomedicine. For rare diseases, nearly 60% of patents were filed and 73% of patents were granted in Q1 2024.

Hypertension related patents lead Alnylam Pharmaceuticals portfolio followed by amyloidosis, and parkinson's disease

Alnylam Pharmaceuticals has highest number of patents in hypertension followed by amyloidosis, parkinson's disease, alzheimer's disease, and cardiomyopathy. For hypertension, nearly 10% of patents were filed and 3% of patents were granted in Q1 2024.

For comprehensive analysis of Alnylam Pharmaceuticals's filings and grants, buy the databook here.

Data Insights


The gold standard of business intelligence.

Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.


GlobalData patents database covers bibliographic from all 100+ patenting authorities. All patents are tagged to 18+ industries and 300+ sub-sectors based on technology classification, keywords, and associated companies. They are also tagged to various industries themes (100+) and technology domains (1800+) of focus.

Patents database further disambiguates assignee names (13m names) and associate corporate tree hierarchy in current/point in time ownerships (320k entities). GlobalData sources content directly from national patent offices on a weekly basis.